Optiscan has been featured in Stockhead, The Australian, and 11 News Corp mastheads for the launch of InSpecta™, a new imaging device designed specifically for the veterinary market.
The article highlights how InSpecta™ leverages Optiscan’s established endomicroscopic imaging technology to provide real-time, high-resolution cellular imaging in veterinary settings. Purpose-built for use during procedures or on freshly excised tissue, InSpecta™ enables immediate visualisation without the need for slides or tissue processing—supporting faster decisions and fewer follow-up procedures.
CEO Dr. Camile Farah said: “Our design team should be extremely proud of their efforts to get this market-changing device to the reveal stage. It can be used for both in vivo and ex vivo applications, broadening the appeal and applicability of the technology to the widest possible audience in veterinary medicine.”
Stockhead – Read the full article here.
The Australian – Read the full article here.
